https://stock.noler.com/us/stock/intec-pharma-ltd https://stock.noler.com/us/stock/intec-pharma-ltd/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/intec-pharma-ltd/accounts-payable-other-current https://stock.noler.com/us/stock/intec-pharma-ltd/accounts-payable-trade-current https://stock.noler.com/us/stock/intec-pharma-ltd/accrued-liabilities-current https://stock.noler.com/us/stock/intec-pharma-ltd/accrued-salaries-current https://stock.noler.com/us/stock/intec-pharma-ltd/accrued-vacation-current https://stock.noler.com/us/stock/intec-pharma-ltd/accumulated-depreciation https://stock.noler.com/us/stock/intec-pharma-ltd/additional-paid-in-capital https://stock.noler.com/us/stock/intec-pharma-ltd/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/intec-pharma-ltd/adjustments-for-decrease-increase-in-other-operating-receivables https://stock.noler.com/us/stock/intec-pharma-ltd/adjustments-for-depreciation-and-amortisation-expense https://stock.noler.com/us/stock/intec-pharma-ltd/adjustments-for-gain-loss-on-disposals-property-plant-and-equipment https://stock.noler.com/us/stock/intec-pharma-ltd/adjustments-for-gains-losses-on-change-in-fair-value-of-derivatives https://stock.noler.com/us/stock/intec-pharma-ltd/adjustments-for-increase-decrease-in-trade-account-payable https://stock.noler.com/us/stock/intec-pharma-ltd/adjustments-for-reconcile-profit-loss https://stock.noler.com/us/stock/intec-pharma-ltd/adjustments-for-share-based-payments https://stock.noler.com/us/stock/intec-pharma-ltd/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/intec-pharma-ltd/amounts-payable-related-party-transactions https://stock.noler.com/us/stock/intec-pharma-ltd/applicable-tax-rate https://stock.noler.com/us/stock/intec-pharma-ltd/asset-impairment-charges https://stock.noler.com/us/stock/intec-pharma-ltd/assets https://stock.noler.com/us/stock/intec-pharma-ltd/assets-noncurrent https://stock.noler.com/us/stock/intec-pharma-ltd/average-number-of-employees https://stock.noler.com/us/stock/intec-pharma-ltd/bank-and-similar-charges https://stock.noler.com/us/stock/intec-pharma-ltd/basic-and-diluted-earnings-loss-per-share https://stock.noler.com/us/stock/intec-pharma-ltd/capital-expenditures https://stock.noler.com/us/stock/intec-pharma-ltd/cash-and-cash-equivalents https://stock.noler.com/us/stock/intec-pharma-ltd/cash-and-equivalents https://stock.noler.com/us/stock/intec-pharma-ltd/cash-and-restricted-cash https://stock.noler.com/us/stock/intec-pharma-ltd/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/intec-pharma-ltd/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/intec-pharma-ltd/cash-flow-breakdown https://stock.noler.com/us/stock/intec-pharma-ltd/cash-flows-from-used-in-decrease-increase-in-shortterm-deposits-and-investments https://stock.noler.com/us/stock/intec-pharma-ltd/cash-flows-from-used-in-financing-activities https://stock.noler.com/us/stock/intec-pharma-ltd/cash-flows-from-used-in-investing-activities https://stock.noler.com/us/stock/intec-pharma-ltd/cash-flows-from-used-in-operating-activities https://stock.noler.com/us/stock/intec-pharma-ltd/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/intec-pharma-ltd/common-stock-value https://stock.noler.com/us/stock/intec-pharma-ltd/comprehensive-income https://stock.noler.com/us/stock/intec-pharma-ltd/cover-page-shares-outstanding https://stock.noler.com/us/stock/intec-pharma-ltd/current-accrued-expenses-and-other-current-liabilities https://stock.noler.com/us/stock/intec-pharma-ltd/current-advances-to-suppliers https://stock.noler.com/us/stock/intec-pharma-ltd/current-assets https://stock.noler.com/us/stock/intec-pharma-ltd/current-assets-ifrs-full https://stock.noler.com/us/stock/intec-pharma-ltd/current-financial-assets-at-fair-value-through-profit-or-loss https://stock.noler.com/us/stock/intec-pharma-ltd/current-government-grants https://stock.noler.com/us/stock/intec-pharma-ltd/current-liabilities https://stock.noler.com/us/stock/intec-pharma-ltd/current-liabilities-ifrs-full https://stock.noler.com/us/stock/intec-pharma-ltd/current-prepaid-expenses https://stock.noler.com/us/stock/intec-pharma-ltd/current-restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/intec-pharma-ltd/damages-sought-value https://stock.noler.com/us/stock/intec-pharma-ltd/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/intec-pharma-ltd/deferred-tax-assets-net https://stock.noler.com/us/stock/intec-pharma-ltd/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/intec-pharma-ltd/deferred-tax-assets-other https://stock.noler.com/us/stock/intec-pharma-ltd/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/intec-pharma-ltd/depreciation https://stock.noler.com/us/stock/intec-pharma-ltd/depreciation-and-amortization https://stock.noler.com/us/stock/intec-pharma-ltd/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/intec-pharma-ltd/effect-of-exchange-rate-changes-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/intec-pharma-ltd/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/intec-pharma-ltd/employee-benefits-expense https://stock.noler.com/us/stock/intec-pharma-ltd/equity https://stock.noler.com/us/stock/intec-pharma-ltd/equity-and-liabilities https://stock.noler.com/us/stock/intec-pharma-ltd/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/intec-pharma-ltd/expense-from-share-based-payment-transactions-with-employees https://stock.noler.com/us/stock/intec-pharma-ltd/finance-costs https://stock.noler.com/us/stock/intec-pharma-ltd/finance-income https://stock.noler.com/us/stock/intec-pharma-ltd/finance-income-cost https://stock.noler.com/us/stock/intec-pharma-ltd/financing-cash-flow https://stock.noler.com/us/stock/intec-pharma-ltd/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/intec-pharma-ltd/foreign-currency-transaction-loss-before-tax https://stock.noler.com/us/stock/intec-pharma-ltd/form-d-other https://stock.noler.com/us/stock/intec-pharma-ltd/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/intec-pharma-ltd/gain-loss-on-securitization-of-financial-assets https://stock.noler.com/us/stock/intec-pharma-ltd/gains-losses-on-financial-assets-at-fair-value-through-profit-or-loss https://stock.noler.com/us/stock/intec-pharma-ltd/gains-on-change-in-fair-value-of-derivatives https://stock.noler.com/us/stock/intec-pharma-ltd/general-and-administrative-expense https://stock.noler.com/us/stock/intec-pharma-ltd/income-loss-attributable-to-parent https://stock.noler.com/us/stock/intec-pharma-ltd/income-tax https://stock.noler.com/us/stock/intec-pharma-ltd/income-tax-expense https://stock.noler.com/us/stock/intec-pharma-ltd/income-taxes-paid https://stock.noler.com/us/stock/intec-pharma-ltd/income-taxes-paid-refund-classified-as-operating-activities https://stock.noler.com/us/stock/intec-pharma-ltd/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/intec-pharma-ltd/increase-decrease-in-cash-and-cash-equivalents https://stock.noler.com/us/stock/intec-pharma-ltd/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/intec-pharma-ltd/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/intec-pharma-ltd/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/intec-pharma-ltd/increase-decrease-through-exercise-of-options https://stock.noler.com/us/stock/intec-pharma-ltd/increase-decrease-through-exercise-of-warrants-equity https://stock.noler.com/us/stock/intec-pharma-ltd/increase-decrease-through-share-based-payment-transactions https://stock.noler.com/us/stock/intec-pharma-ltd/insider-transactions-stock-options https://stock.noler.com/us/stock/intec-pharma-ltd/interest-income-deposits-with-financial-institutions https://stock.noler.com/us/stock/intec-pharma-ltd/interest-income-on-deposits https://stock.noler.com/us/stock/intec-pharma-ltd/interest-receivable https://stock.noler.com/us/stock/intec-pharma-ltd/interest-receivable-current https://stock.noler.com/us/stock/intec-pharma-ltd/interest-received-classified-as-operating-activities https://stock.noler.com/us/stock/intec-pharma-ltd/investing-cash-flow https://stock.noler.com/us/stock/intec-pharma-ltd/issue-of-equity https://stock.noler.com/us/stock/intec-pharma-ltd/lease-cost https://stock.noler.com/us/stock/intec-pharma-ltd/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/intec-pharma-ltd/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/intec-pharma-ltd/liabilities https://stock.noler.com/us/stock/intec-pharma-ltd/liabilities-assumed https://stock.noler.com/us/stock/intec-pharma-ltd/liabilities-noncurrent https://stock.noler.com/us/stock/intec-pharma-ltd/losses-on-change-in-fair-value-of-derivatives https://stock.noler.com/us/stock/intec-pharma-ltd/marketable-securities https://stock.noler.com/us/stock/intec-pharma-ltd/marketable-securities-current https://stock.noler.com/us/stock/intec-pharma-ltd/marketable-securities-gain-loss https://stock.noler.com/us/stock/intec-pharma-ltd/net-change-in-cash https://stock.noler.com/us/stock/intec-pharma-ltd/net-foreign-exchange-gain https://stock.noler.com/us/stock/intec-pharma-ltd/net-income https://stock.noler.com/us/stock/intec-pharma-ltd/noncurrent-assets https://stock.noler.com/us/stock/intec-pharma-ltd/noncurrent-derivative-financial-liabilities https://stock.noler.com/us/stock/intec-pharma-ltd/nonoperating-gains-losses https://stock.noler.com/us/stock/intec-pharma-ltd/nontrade-receivables-current https://stock.noler.com/us/stock/intec-pharma-ltd/number-of-shares-authorised https://stock.noler.com/us/stock/intec-pharma-ltd/number-of-shares-issued https://stock.noler.com/us/stock/intec-pharma-ltd/oci-net-of-tax-exchange-differences-on-translation https://stock.noler.com/us/stock/intec-pharma-ltd/operating-cash-flow https://stock.noler.com/us/stock/intec-pharma-ltd/operating-income https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-assets https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-expense https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-liability https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-liability-current https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-payments https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-payments-due https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-payments-due-2 https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-payments-due-current https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/intec-pharma-ltd/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/intec-pharma-ltd/operating-leases-rent-expense-net https://stock.noler.com/us/stock/intec-pharma-ltd/operating-loss-carryforwards https://stock.noler.com/us/stock/intec-pharma-ltd/other-accrued-liabilities-current https://stock.noler.com/us/stock/intec-pharma-ltd/other-comprehensive-income https://stock.noler.com/us/stock/intec-pharma-ltd/other-current-receivables https://stock.noler.com/us/stock/intec-pharma-ltd/other-employee-expense https://stock.noler.com/us/stock/intec-pharma-ltd/other-gains-losses https://stock.noler.com/us/stock/intec-pharma-ltd/other-income https://stock.noler.com/us/stock/intec-pharma-ltd/other-noncurrent-assets https://stock.noler.com/us/stock/intec-pharma-ltd/other-noncurrent-financial-assets https://stock.noler.com/us/stock/intec-pharma-ltd/other-noncurrent-liabilities https://stock.noler.com/us/stock/intec-pharma-ltd/other-receivables-net-current https://stock.noler.com/us/stock/intec-pharma-ltd/other-reserves https://stock.noler.com/us/stock/intec-pharma-ltd/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/intec-pharma-ltd/payments-to-acquire-other-investments https://stock.noler.com/us/stock/intec-pharma-ltd/postemployment-benefit-expense-defined-contribution-plans https://stock.noler.com/us/stock/intec-pharma-ltd/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/intec-pharma-ltd/prepaid-expense-current https://stock.noler.com/us/stock/intec-pharma-ltd/pretax-income https://stock.noler.com/us/stock/intec-pharma-ltd/proceeds-from-disposal-of-noncurrent-assets-or-disposal-groups-classified-as-held-for-sale-and-discontinued-operations https://stock.noler.com/us/stock/intec-pharma-ltd/proceeds-from-exercise-of-options https://stock.noler.com/us/stock/intec-pharma-ltd/proceeds-from-issuing-shares https://stock.noler.com/us/stock/intec-pharma-ltd/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/intec-pharma-ltd/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/intec-pharma-ltd/proceeds-from-sales-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/intec-pharma-ltd/proceeds-from-stock-issued https://stock.noler.com/us/stock/intec-pharma-ltd/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/intec-pharma-ltd/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/intec-pharma-ltd/profit-loss https://stock.noler.com/us/stock/intec-pharma-ltd/profit-loss-before-tax https://stock.noler.com/us/stock/intec-pharma-ltd/profit-loss-from-operating-activities https://stock.noler.com/us/stock/intec-pharma-ltd/property-plant-and-equipment https://stock.noler.com/us/stock/intec-pharma-ltd/property-plant-and-equipment-gross https://stock.noler.com/us/stock/intec-pharma-ltd/property-plant-equipment https://stock.noler.com/us/stock/intec-pharma-ltd/public-float https://stock.noler.com/us/stock/intec-pharma-ltd/purchase-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/intec-pharma-ltd/research-and-development https://stock.noler.com/us/stock/intec-pharma-ltd/research-and-development-expense https://stock.noler.com/us/stock/intec-pharma-ltd/restricted-cash https://stock.noler.com/us/stock/intec-pharma-ltd/restricted-cash-current https://stock.noler.com/us/stock/intec-pharma-ltd/retained-earnings https://stock.noler.com/us/stock/intec-pharma-ltd/retained-earnings-ifrs-full https://stock.noler.com/us/stock/intec-pharma-ltd/severance-costs https://stock.noler.com/us/stock/intec-pharma-ltd/sga-expense https://stock.noler.com/us/stock/intec-pharma-ltd/share-premium https://stock.noler.com/us/stock/intec-pharma-ltd/share-price https://stock.noler.com/us/stock/intec-pharma-ltd/shareholders-equity https://stock.noler.com/us/stock/intec-pharma-ltd/shares-authorized https://stock.noler.com/us/stock/intec-pharma-ltd/shares-issued https://stock.noler.com/us/stock/intec-pharma-ltd/short-term-lease-cost https://stock.noler.com/us/stock/intec-pharma-ltd/social-security-contributions https://stock.noler.com/us/stock/intec-pharma-ltd/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/intec-pharma-ltd/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/intec-pharma-ltd/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/intec-pharma-ltd/stock-based-compensation https://stock.noler.com/us/stock/intec-pharma-ltd/stock-issued-new-shares-sold https://stock.noler.com/us/stock/intec-pharma-ltd/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/intec-pharma-ltd/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/intec-pharma-ltd/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/intec-pharma-ltd/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/intec-pharma-ltd/tax-expense-other-than-income-tax-expense https://stock.noler.com/us/stock/intec-pharma-ltd/total-assets https://stock.noler.com/us/stock/intec-pharma-ltd/total-liabilities https://stock.noler.com/us/stock/intec-pharma-ltd/total-liabilities-and-equity https://stock.noler.com/us/stock/intec-pharma-ltd/trade-and-other-payables-to-trade-suppliers https://stock.noler.com/us/stock/intec-pharma-ltd/trade-and-other-payables-undiscounted-cash-flows https://stock.noler.com/us/stock/intec-pharma-ltd/unrecognized-tax-benefits https://stock.noler.com/us/stock/intec-pharma-ltd/unused-tax-losses-for-which-no-deferred-tax-asset-recognised https://stock.noler.com/us/stock/intec-pharma-ltd/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/intec-pharma-ltd/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/intec-pharma-ltd/variable-lease-cost https://stock.noler.com/us/stock/intec-pharma-ltd/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/intec-pharma-ltd/weighted-average-shares